Skip to main content

Table 1 Characteristics of the population.

From: Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae

FACTOR

CASE FATALITY WITH

FACTOR

CASE FATALITY WITHOUT

FACTOR

RELATIVE RISK

(95% CI)

 

P-VALUE

Male

6/44 (14%)

10/35 (29%)

0.48 (0.19-1.19)

 

0.09

Charlson ≥ median(4)

(Age Adjusted)

12/45 (27%)

4/34 (12%)

2.27 (0.80-6.41)

 

0.09

Cerebrovascular Disease

1/3 (33%)

15/76 (20%)

1.69 (0.32-8.91)

 

NS

Congestive Heart Failure

1/7 (14%)

15/72 (21%)

0.69 (0.11-4.45)

 

NS

Chronic Pulmonary Disease

0/1 (0%)

16/78 (21%)

0.00()

 

NS

Dementia

1/4 (25%)

15/75 (20%)

1.25 (0.22-7.24)

 

NS

Diabetes without complications

0/9 (0%)

16/70 (23%)

0.00()

 

NS

Diabetes with complications

1/10 (10%)

15/69 (22%)

0.46 (0.07-3.11)

 

NS

Paraplegia

0/1 (0%)

16/78 (21%)

0.00()

 

NS

Mild Liver Disease

3/4 (75%)

13/75 (17%)

4.32 (2.04-9.17)

 

0.03

Severe Liver Disease

2/4 (50%)

14/75 (19%)

2.68 (0.90-7.95)

 

NS

Malignancy

5/21 (24%)

11/58 (19%)

1.25 (0.49-3.19)

 

NS

Metastatic

0/1 (0%)

16/78 (21%)

0.00()

 

NS

Myocardial Infarction

1/3 (33%)

15/76 (20%)

1.69 (0.32-8.91)

 

NS

Peripheral Vascular Disease

0/1 (0%)

16/78 (21%)

0.00()

 

NS

Peptic Ulcer Disease

0/2 (0%)

16/77 (21%)

0.00()

 

NS

Rheumatologic

2/4 (50%)

14/75 (19%)

2.68 (0.90-7.95)

 

NS

Renal

5/19 (26%)

11/60 (18%)

1.43 (0.57-3.61)

 

NS

Dialysis

2/5 (40%)

14/74 (19%)

2.11 (0.65-6.83)

 

NS